{"id":"W4399571397","doi":"10.1200/jco.2024.42.16_suppl.tps8654","title":"Beamion LUNG-2: A phase III randomized controlled trial of zongertinib (BI 1810631) versus standard of care (SoC) in patients with locally advanced/metastatic non-squamous non-small cell lung cancer (NSCLC) harboring <i>HER2</i> tyrosine kinase domain (TKD) mutations.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; non-small cell lung cancer (NSCLC); Oncology; Standard of care; Lung cancer; Lung; Internal medicine; Clinical endpoint; Randomized controlled trial; A549 cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001828385,0.001820627,0.001973351,0.0004515722,0.0003575461,0.001208385,0.001179663,0.001777097,0.008072942],"category_scores_gemma":[0.001130686,0.0005510098,0.001826551,0.0003859409,0.0009514096,0.001255289,0.0004069267,0.00390756,0.00122361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001198775,"about_ca_system_score_gemma":0.001343727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001468303,"about_ca_topic_score_gemma":0.005702189,"domain_scores_codex":[0.9995108,0.0002464403,0.00002176265,0.00009444135,0.00003087246,0.00009574012],"domain_scores_gemma":[0.9994621,0.0001183958,0.0001341937,0.00003279365,0.00003180756,0.0002208198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9413137,0.01664487,0.001073588,0.001148112,0.001350879,0.00006321983,0.00009287708,0.0007525472,0.005712428,0.0002809924,0.003622686,0.02794412],"study_design_scores_gemma":[0.9165335,0.07953983,0.00138028,0.00003699741,0.0003345194,0.00005779434,0.00002728429,0.0004867554,0.000389024,0.0001319291,0.001067852,0.00001413319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9651873,0.01038566,0.001145773,0.002358086,0.0009718745,0.009506698,0.004591552,0.0004986845,0.005354266],"genre_scores_gemma":[0.9669592,0.004973239,0.002381747,0.003716539,0.0005580147,0.009656505,0.004300012,0.00006477261,0.007389966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008072942,"threshold_uncertainty_score":0.02700669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842159233727801,"score_gpt":0.4110515065430091,"score_spread":0.3926299142057311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}